We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+16.47%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.6B
AUM Growth
+$842M
Cap. Flow
-$440M
Cap. Flow %
-4.14%
Top 10 Hldgs %
16.26%
Holding
2,304
New
726
Increased
425
Reduced
494
Closed
615

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$151M
3
BSX icon
Boston Scientific
BSX
+$121M
4
AMZN icon
Amazon
AMZN
+$104M
5
TRU icon
TransUnion
TRU
+$81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.87%
2 Healthcare 20.58%
3 Financials 10.9%
4 Technology 10.13%
5 Industrials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSTI icon
1426
SoundThinking
SSTI
$107M
$110K ﹤0.01%
+2,838
New +$122K
DVY icon
1427
iShares Select Dividend ETF
DVY
$24B
$108K ﹤0.01%
+1,102
New +$106K
PGTI
1428
DELISTED
PGT, Inc.
PGTI
$108K ﹤0.01%
7,765
-74,690
-91% -$1.18M
ALSN icon
1429
Allison Transmission
ALSN
$10.1B
$106K ﹤0.01%
+2,358
New +$112K
PFSW
1430
DELISTED
PFSweb, Inc.
PFSW
$104K ﹤0.01%
+19,991
New +$119K
ACRS icon
1431
Aclaris Therapeutics
ACRS
$730M
$103K ﹤0.01%
+17,245
New +$114K
PNQI icon
1432
Invesco NASDAQ Internet ETF
PNQI
$501M
$103K ﹤0.01%
+3,805
New +$96.7K
VC icon
1433
Visteon
VC
$2.77B
$103K ﹤0.01%
1,522
-53,945
-97% -$4.06M
TPGH.WS
1434
DELISTED
TPG Pace Holdings Corp. Warrants, each exercisable for one Class A Ordinary Share at an exercise pri
TPGH.WS
$100K ﹤0.01%
99,997
CSBR icon
1435
Champions Oncology
CSBR
$85.1M
$99K ﹤0.01%
+10,066
New +$100K
MEDP icon
1436
Medpace
MEDP
$16.8B
$99K ﹤0.01%
+1,677
New +$100K
BMA icon
1437
Banco Macro
BMA
$5.7B
$98K ﹤0.01%
+2,135
New +$110K
IYE icon
1438
iShares US Energy ETF
IYE
$1.74B
$98K ﹤0.01%
+2,733
New +$95.6K
NTIC icon
1439
Northern Technologies International Corp
NTIC
$76.4M
$98K ﹤0.01%
+7,336
New +$108K
AOSL icon
1440
Alpha and Omega Semiconductor
AOSL
$923M
$95K ﹤0.01%
8,199
-17,102
-68% -$189K
SONY icon
1441
Sony
SONY
$123B
$95K ﹤0.01%
11,275
-1,168,915
-99% -$10.9M
QUOT
1442
DELISTED
Quotient Technology Inc
QUOT
$95K ﹤0.01%
+9,635
New +$98.9K
NPTN
1443
DELISTED
NEOPHOTONICS CORP
NPTN
$95K ﹤0.01%
15,037
+14,740
+4,963% +$103K
PENN icon
1444
PENN Entertainment
PENN
$2.74B
$94K ﹤0.01%
4,642
-687,920
-99% -$16.1M
CACI icon
1445
CACI
CACI
$10.8B
$93K ﹤0.01%
+513
New +$87.4K
MDWD icon
1446
MediWound
MDWD
$183M
$93K ﹤0.01%
+2,666
New +$89.7K
TBPH icon
1447
Theravance Biopharma
TBPH
$874M
$92K ﹤0.01%
4,080
JAX
1448
DELISTED
J. Alexander's Holdings, Inc.
JAX
$92K ﹤0.01%
9,341
+8,896
+1,999% +$81.7K
STNLW
1449
DELISTED
Sentinel Energy Services Inc. Warrant
STNLW
$92K ﹤0.01%
+135,768
New +$109K
ECH icon
1450
iShares MSCI Chile ETF
ECH
$1.01B
$91K ﹤0.01%
+2,100
New +$94.4K

Similar funds

Marshall Wace's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace held 2,304 positions worth $10.6B, up 8.6% from $9.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace withdrew a net $440M in Q1 2019, closing 615 positions and reducing 494 holdings. Its most notable exit was Shire pic, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Marshall Wace opened a new position in TransUnion worth $87.4M.

  • Marshall Wace's largest Q1 2019 buy was TransUnion: 1,307,679 shares worth $87.4M.
  • Marshall Wace added most to McDonald's in Q1 2019, an estimated $240M increase.
  • Marshall Wace's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $132M.
  • Marshall Wace fully exited Shire pic in Q1 2019, selling an estimated $166M.
  • Marshall Wace's ten largest holdings make up 16% of its $10.6B portfolio in Q1 2019.
  • Marshall Wace opened 726 new positions and closed 615 in Q1 2019.
  • Marshall Wace's portfolio value rose 8.6% quarter-over-quarter to $10.6B.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.